Delay in the diagnosis of Tuberculosis (TB) remains a major challenge against achieving effective TB prevention and control. Though a number of studies with inconsistent findings were conducted in Ethiopia; unavailability of a nationwide study determining the median time of patient delays to TB diagnosis is an important research gap. Therefore, this study aimed to determine the pooled median time of the patient delay to TB diagnosis and its determinants in Ethiopia.
Methods
We followed PRISMA checklist to present this study. We searched from Google Scholar, PubMed, Science Direct, Web of Science, CINAHL, and Cochrane Library databases for studies. The comprehensive search for relevant studies was done by two of the authors (MA and LY) up to the 10th of October 2019. Risk of bias was assessed using the Newcastle-Ottawa scale adapted for observational studies. Data were pooled and a random effect meta-analysis model was fitted to provide the overall median time of patient delay and its determinants in Ethiopia. Furthermore, subgroup analyses were conducted to investigate how the median time of patient delay varies across different groups of studies.
Results
Twenty-four studies that satisfied the eligibility criteria were included. Our meta-analysis showed that the median time of the patient delay was 24.6 (95%CI: 20.8–28.4) days. Living in rural area (OR: 2.19, 95%CI: 1.51–3.18), and poor knowledge about TB (OR: 2.85, 95%CI: 1.49–5.47) were more likely to lead to prolonged delay. Patients who consult non-formal health providers (OR: 5.08, 95%CI: 1.56–16.59) had a prolonged delay in the diagnosis of TB. Moreover, the narrative review of this study showed that age, educational level, financial burden and distance travel to reach the nearest health facility were significantly associated with a patient delay in the diagnosis of TB.
Conclusions
In conclusion, patients are delayed more-than three weeks in the diagnosis of TB. Lack of awareness about TB, consulting non-formal health provider, and being in the rural area had increased patient delay to TB diagnosis. Increasing public awareness about TB, particularly in rural and disadvantaged areas could help to early diagnosis of TB.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
TB
Tuberculosis
PRISMA
Preferred Reporting Items for Systematic Reviews and Meta-Analysis
Background
In 2017, an estimated 1.6 million people died due to treatable and curable disease called tuberculosis (TB) [1]. It is one of the top ten causes of death worldwide, and over 95% of cases and deaths are occurring in developing countries [2]. Though Ethiopia has achieved the reduction of TB incidence by halve, the decline of its incidence and prevalence rates has been comparatively slow [3].
In developing countries, delay in the diagnosis of TB remains a major challenge against effective management of the disease. Previous report showed that 42% patients are delayed to TB treatment in low-and middle-income countries [4]. Delay in seeking care worsen the burden of TB and the cost of care for patients, families and the overall public health system [5]. Patient-level and system-level barriers including limited knowledge, attitude, belief regarding TB, economic burdens, centralization of services, health system delays, and geographical access to healthcare influenced timely TB treatment initiation and compliances [6, 7].
Anzeige
The average time of patient delay in the diagnosis of TB and its determinants were reported by a number of studies [8‐22]. However, the reported average time and determinant factors in these fragmented studies vary depending on the characteristics of study participants, the type of design employed and the variables analyzed. Having conclusive evidence by combining the existing studies is significant to have quality evidence on the national TB prevention and control program. Thus, this systematic review and meta-analysis aimed to determine the pooled median time of delay in the diagnosis of TB patients and to identify its determinants. This finding will help health-policy makers and other concerned body to apply efficient interventions, and to improve the health care seeking behavior of TB patients.
Methods
Study design and setting
A study that aimed to estimate the pooled median time of patient delay in the diagnosis of TB and to identify its determinants was conducted in Ethiopia. The country is subdivided into ten national regional states: namely Amhara, Tigray, Oromia, Afar, Benishangul-Gumuz, Somali, Southern Nations Nationalities and People Region (SNNPR), Sidama, Gambella, Harari, and two city administrative states (Dire Dawa city council and Addis Ababa city administration).
Eligibility criteria
Criteria for including studies
Study design
All health facility-based cross-sectional studies reporting a patient delay in the diagnosis of pulmonary TB.
Study setting
All studies reporting a patient delay in the diagnosis of pulmonary TB conducted in Ethiopia.
Participants
All smear positive and negative pulmonary TB patients.
Outcome
Studies which report the median time of patient delay for TB diagnosis.
Articles
Published and unpublished studies.
Criteria for excluding studies
We excluded articles that were not fully accessed after at least two email contacts of the principal investigator.
Searching for studies
We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) checklist to present this study [23]. The comprehensive search for potential studies was conducted by two of the authors (MA and LY) up to the 10th of October 2019 without limitation to the year of publication. Two experienced review authors (MA and LY) searched from Google Scholar, Science Direct, PubMed, Cochrane library, Web of Science, and CINAHL databases for studies. The search from the above stated databases was performed using the following keywords: “patient delay” OR “total delay” AND “determinants” OR “factors” AND “Ethiopia”.
Outcome measures and data extraction
Patient delay in the diagnosis of TB is the outcome variable of this study. It is the time from symptom onset to first consultation of the formal health system. Symptom onset referred to the time at which the first symptom such as chronic cough, fever, weight loss and night sweats of the illness began. Furthermore, the patient delay was categorized using a median cutoff point of 30 days. That is, greater than 30 days was taken as a prolonged patient delay. All relevant information from the included studies were extracted independently by two (MA and MAA) of authors after data extraction checklist development. It includes; the last name of the first author, publication year, the region of the study conducted, data collection period, study population, sample size, response rate, and median time of patient delay [24].
Quality assessment tool
Two reviewers (MA and DBK) assessed the quality of articles before inclusion to maintain methodological validity. The Newcastle-Ottawa Scale adapted for cross-sectional studies was used to assess the risk of bias [25]. The tool organized in three sections with a maximum of ten score. The first section scored a maximum of five stars and focuses on the representativeness of the sample. The second section concerned on how the confounding variables controlled with a maximum of two stars. The third section is focused with the outcomes and statistical analysis of study with a possibility of three stars to be gained.
Anzeige
Finally, the average score provided by two reviewers was taken. Articles scored seven and above were considered as achieving high quality. This cut-off point was considered after referring previous literature [26].
Data processing and analysis
All relevant information was extracted using Microsoft excel software. R statistical software employed for meta-analysis. We used the quintile estimation method to estimate the overall medians time among the included studies. This approach had considerably lower absolute percent error than pooled means estimated via transformation-based approaches [27]. Bowley’s coefficient of skewness (SKb) was used to measure the skewness of data and if the mean SKb greater than 0.1 median-based approaches are suggested.
We also conducted a meta-analysis on factors of patients delay in the diagnosis of TB. Since most of the included studies reported that the median patient delay was 30 days, we used it as a cut of point to dichotomize patient’s delay. Moreover, subgroup analyses were conducted to investigate how the median of patient delay in the diagnosis of TB varies across different subgroups of the studies. The region of study conducted, year of publication, and the number of study participants incorporated are subgroups studied in this review.
Results
Search results
Figure 1, shows the number of literature searched, study selection, and the number of studies included. A total of 750 articles were identified during our search, and then 477 articles were excluded due to duplication. Twenty-four studies that satisfied the eligibility criteria were included in this systematic review and meta-analysis.
Fig. 1
Flow chart diagram describing the selection of studies included in the systematic review and meta-analysis of patient delay in diagnosis of tuberculosis in Ethiopia
×
Description of the included studies
In this study, we included a total of twenty-four articles (Table 1). All the included studies were institutional-based cross-sectional. Administratively, nine (41.7%) studies were conducted in the Amhara region, four studies in Oromia region, three studies in South Nations Nationalities and Peoples Regions (SNNPR), and two studies in Addis Ababa. The publication year of the included studies was between 2002 and 2019. The number of study participants among included studies ranged from 105 to 735. The smallest reported median time of the patient delay in the diagnosis of TB was 17 days [28], while the highest was 63 days [8]. Two-third (66.67%) of the included studies had a high quality (Table S1).
Table 1
Characteristics of the included studies conducted in Ethiopia on patients delay in Tuberculosis diagnosis
SNNRP Southern nations, nationalities, and peoples’ region, NR Not Report, SPPTB Smear positive pulmonary tuberculosis, SN smear negative, EPTB extra pulmonary tuberculosis
* = P < 0.05 (The 95%CI does not include one)
Magnitude of patient delay in the diagnosis of TB
To pool the median time of the patient delay, we included studies that report the following summary measures; sample size, median, first quartile and third quartile. Finally, a total of twelve primary studies were included. The pooled median time of patient delay in the diagnosis of TB was 24.6 (95%CI: 20.8–28.4) days.
Subgroup analysis was undertaken by the region of study conducted, publication year, sample size (below median versus above median), and the quality of the study.
The highest median time of the patient delay to TB diagnosis was reported in SNNPR (27.2 (95%CI: 22.3–32.0)) days, while the smallest median time to TB diagnosis was observed in the Oromiya region (15.0 (95%CI: 12.7–17.3)) days. Consequently, the overall median time of patient delay to TB diagnosis was 25.8 (95%CI: 21.6–29.9) days among articles published before 2015, while it was 24.3 (95%CI: 18.0–30.5) days among articles published after 2015. In addition, the overall median time of the patient delay to TB diagnosis was 23.8 (95%CI: 18.7–28.9) days among articles included less-than 384 study participants, while it was 25.9 (95%CI: 19.3–32.5) days among articles included 384 and above study participants (Table 2).
Table 2
Subgroup analysis of studies included in meta-analysis on patient delay in diagnosis of pulmonary tuberculosis in Ethiopia (n = 12)
Subgroup
Number of included studies
Random effects (95%CI)
Test of heterogeneity (I2)
p- value
By region
Amhara
6
26.8 (20.9–32.6)
90.6%
< 0.001
SNNPR
2
27.2 (22.3–32.0)
81.9%
< 0.001
Addis Ababa
1
17.0 (15.0–18.9)
_
Oromiya
1
15.0 (12.7–17.3)
_
Afar
1
20.0 (14.6–25.4)
_
Tigray
1
30.0 (26.6–33.4)
–
By publication year
Before 2015
5
25.8 (21.6–29.9)
71.5%
< 0.001
After 2015
7
24.3 (18.0–30.5)
97.8%
< 0.001
By sample size
< 384
6
23.8 (18.7–28.9)
90.2%
< 0.001
≥ 384
6
25.9 (19.3–32.5)
97.5%
< 0.001
Overall
24.6 (20.8–28.4)
94.9%
Anzeige
Determinants of patient delay in the diagnosis of TB
Significant determinants of patient delay in the diagnosis of TB among the included studies were presented in (Table S2). Fourteen studies examined the association between residence and patient delay in the diagnosis of TB. Consequently, a significant association between residence and patient delay was reported by eight studies [8‐15]. Patients living in the rural area had prolonged delay compared to patients living in urban area. Our meta-analysis also revealed that patients from rural area were more likely to have a prolonged delay (OR: 2.19, 95%CI: 1.51–3.18) (Fig. 2). Among nine studies that examine the association between knowledge about TB and patients delay, a significant result was reported by six studies [9, 11, 12, 16‐18]. Our pooled analysis showed that patient delay is more likely among patients who had poor knowledge about TB (OR: 2.85, 95%CI: 1.49–5.47) (Fig. 3). Moreover, this meta-analysis showed that seeking treatment from non-formal providers was a significant risk factor for longer health care-seeking delay of TB (OR: 5.08, 95%CI: 1.56–16.59) (Fig. 4).
Fig. 2
The pooled odds ratio of the association between residence and patient delay in the diagnosis of TB in Ethiopia
Fig. 3
The pooled odds ratio of the association between knowledge and patient delay in the diagnosis of TB in Ethiopia
Fig. 4
The pooled odds ratio of the association between first action to illness and patient delay in the diagnosis of TB in Ethiopia
×
×
×
A significant association between the age of patient and prolonged delay was reported by five studies [17‐20, 37]. Younger age group had a shorter time of TB diagnosis. In addition, a significant association between the educational level of a patient and patient delay was reported by five studies [8, 10, 13, 21, 22]. Consequently, as the educational level of the patient increases the likelihood of patient delay to TB diagnosis will be decreased. The other important variable which shows significant association to patient delay was time to reach the nearest health facility [8, 9, 11, 18, 22, 28, 37]. As the time elapses to reach the formal health provider increase, patients are more likely to have a prolonged delay. From the included studies, three studies reported that financial problem [9, 13, 16] was associated with patient delay to diagnosis. Participants who had better economic status are less likely to have prolonged delays.
Discussion
This study was conducted to determine the pooled median time of patient delay in the diagnosis TB and to identify its determinants. The median time of patient delay among the included studies ranged from 17 to 63 days. The meta-analysis showed that the overall median time of patient delay in Ethiopia was 24.6 (95%CI: 20.8–28.4) days. This result is comparable with other studies conducted in Tanzania, Uganda and India [38‐40]. On the other hand, the median time of patient delay obtained in this study was shorter than previous studies conducted Mozambique, Angola and Ghana [41‐43], and higher than studies conducted in Cameroon and China [44, 45]. The possible explanation for this inconsistency might be differences in the socio-economic and demographic characteristics of study participants [46, 47]. The subgroup analysis by year of publication showed that the median time of patient delay among articles published after 2015 was shorter than articles published prior to 2015. This could be due to changes in policy and guidelines. In addition, a longer median time of patient delay was observed among studies with larger sample size (≥384) than studies with smaller sample size (< 384).
The pooled result of this study revealed that patients living in rural area were more likely to have a prolonged delay. This finding is consistent with a study conducted in Nigeria [48]. This might be due to the shortage of formal health providers in rural area of Ethiopia [49]. Long distance travelling discourages tuberculosis treatment initiation [7]. In addition, previous reports revealed that in rural areas, the first action to illness is consulting traditional healers [50]. Furthermore, a study conducted in the rural area of Nigeria showed that about 84% of TB patients first consulting a non-formal health provider [48].
Anzeige
Our pooled analysis showed that patient delay is more likely among patients who had poor knowledge about TB. This result is comparable with a study conducted in Mozambique, Bangladesh, and India [42, 51, 52]. The reason for this result might be patients who have poor knowledge of TB believe that TB is acquired from evil and they seek traditional healers or religious leaders to be freed from evil spirits [53]. This meta-analysis showed that seeking treatment from non-formal providers was a significant risk factor for longer patient delay of TB. A comparable result was obtained from studies conducted in low and middle-income countries, Mozambique, Uganda and Tanzania [4, 40, 42, 54]. This might be due to low knowledge tuberculosis [47]. Number and type of non-formal provider first consulted were the most important risk factors for delay [38].
Due to inconsistent classification of age, we were unable to show the pooled effects. In two studies, patient delay was longer among study participants whose age are forty five and above [19, 37]. The possible reason for this result might be older patients are dependent on others help and may not early seek health care. A study conducted in southern Ethiopia indicated that the health care seeking behaviors among elderly people is generally low [55].
Our narrative reviews also showed that the educational level of respondents was associated with patient delay in the diagnosis of TB. Consequently, as the educational level of patient increases the likelihood of patient delay to TB diagnosis will decreases, as found in few studies [8, 10, 13, 21]. This result is supported by other studies conducted in South Africa [46]. The possible reason for this result might be study participants who had higher educational levels were more likely to be aware of TB than those who had no education [56].
In addition, as the time elapse to reach the formal health provider increase patients are more-likely to have prolonged delay [8, 9, 11, 18, 28, 37]. This result is consistent with a study conducted in Angola and Uganda [41, 57]. A systematic review and meta-analysis study conducted in Asia revealed that long travel time to the nearest healthcare provider led to longer patient delays [58].
Anzeige
Participants who had better economic status are less-likely to have prolonged delay [9, 13, 16]. The possible explanation for this result might be patients suffered high economic losses prior to diagnosis [59]. The total median cost incurred from first consultation to diagnosis was $27 per patient in Ethiopia [5].
Limitations
This systematic review and meta-analysis was not without limitations. Firstly, the review was limited to only articles published in the English language. Secondly, all of the included studies were institution based cross-sectional studies, which limits assessment of the cause-effect relationships. Thirdly, there is sizable in-consistency across the included studies. The observed heterogeneity might be described by the quality of the studies.
Conclusions
In conclusion, patients are delayed more-than three weeks in the diagnosis of TB. Lack of awareness about TB, consulting non-formal health provider, and living in the rural area had increased patient delay to TB diagnosis. Increasing public awareness about TB and active case finding, particularly in rural and disadvantaged areas could help to early diagnosis of TB.
Acknowledgements
Authors of primary study.
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.
Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.
Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.
Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.
Update Innere Medizin
Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.
